SAVSU will be co-presenting Supply Chain Requirements for Cell & Gene Therapy workshop at the Global Clinical Supply Group Spring Conference at the Hyatt Regency Tamaya Resort & Spa in Albuquerque, NM, on April 24th and 25th, 2017.
This marks the 30th year for the Annual Conference. The workshop will be delivered over two days by Kevin O’Donnell, VP Cold Chain Standards, Practices & Compliance at SAVSU Technologies, and Krisztina Poda, Director of Business Operations Cell/Gene Therapy, at Pfizer Inc., Global Clinical Supply.
This will be the first year GCSG has had a workshop specifically targeting Cell & Gene Therapy clinical trials.
Workshop Title: Supply Chain Requirements for Cell & Gene Therapy
The distribution and handling of precious gene therapy supplies requires a higher level of controls to ensure quality and sustainability.
Attendees will be able to:
(1) Compare and contrast the logistics requirements of standard cold chain products versus cell and gene therapy products
(2) List at least two (2) concerns in the handling of cell and gene therapy clinical materials
(3) Describe the appropriate classification and labeling of cell and gene therapy products to ensure compliant transportation